June 22, 2:30 pm PDT / 5:30 pm EDT

The COVID-19 pandemic has proved that global cooperation and public-private partnerships can successfully strive together in times of crisis to make a tangible impact. Inspired by these collaborative efforts, this panel will explore how uniting to defeat a common enemy, cancer, might shape the future of cancer treatment and care. Despite tremendous innovation in oncology care in recent years, with breakthroughs in diagnosis and treatment driving increases in survival for many forms of cancer, it is still one of the leading causes of death worldwide. How might cooperation across borders, public-private partnerships, and insights from the patient community, regulators, and non-government organizations spur research and technological innovation in cancer treatment? How could global collaboration catalyze the development of new therapies as well as the biological understanding of cancer?
 

Moderator

Tina Reed
Health Editor, Axios
 

Speakers

Paul G. Kluetz
Deputy Director, Oncology Center of Excellence, US Food and Drug Administration

John Oyler
Co-Founder, Chairman and CEO, BeiGene

Solange Peters
President, European Society for Medical Oncology